InsidersTradesSigma
Follow the 쎌바이오텍 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 쎌바이오텍 has recorded 14 public disclosures. The latest transaction was disclosed on 9 December 2025 (Purchase). Among the most active insiders: 쎌바이오텍. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
14 of 14 declarations
Cell Biotech es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones biofarmacéuticas innovadoras.